Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 478653, 17 pages
http://dx.doi.org/10.1155/2014/478653
Research Article

In Vivo and In Vitro Antitumor Effects of Platycodin D, a Saponin Purified from Platycodi Radix on the H520 Lung Cancer Cell

1Department of Pulmonary Internal Medicine of Anatomy and Histology, College of Korean Medicine, Daegu Haany University, No. 1 Haanydae-ro, Gyeongsan, Gyeongbuk 712-715, Republic of Korea
2Department of Preventive Medicine, College of Korean Medicine, Daegu Haany University, Gyeongsan 712-715, Republic of Korea
3The Medical Center for Globalization of Herbal Medicine, Daegu Haany University, Gyeongsan 712-715, Republic of Korea
4Department of Natural Medicine Resources, Semyung University, Hecheon 390-711, Republic of Korea
5Department of Anatomy and Histology, College of Korean Medicine, Daegu Haany University, No. 1 Haanydae-ro, Gyeongsan, Gyeongbuk 712-715, Republic of Korea

Received 6 August 2014; Revised 8 October 2014; Accepted 18 October 2014; Published 13 November 2014

Academic Editor: Menaka C. Thounaojam

Copyright © 2014 Jae Chan Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA: A Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Tonon, K.-K. Wong, G. Maulik et al., “High-resolution genomic profiles of human lung cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 27, pp. 9625–9630, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Sher, G. K. Dy, and A. A. Adjei, “Small cell lung cancer,” Mayo Clinic Proceedings, vol. 83, no. 3, pp. 355–367, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. E. Maziak, B. R. Markman, J. A. MacKay, and W. K. Evans, “Photodynamic therapy in nonsmall cell lung cancer: a systematic review,” The Annals of Thoracic Surgery, vol. 77, no. 4, pp. 1484–1491, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C. G. Ferreira, C. Huisman, and G. Giaccone, “Novel approaches to the treatment of non-small cell lung cancer,” Critical Reviews in Oncology/Hematology, vol. 41, no. 1, pp. 57–77, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Yang, M. S. Allen, M. C. Aubry et al., “Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003,” Chest, vol. 128, no. 1, pp. 452–462, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. P. C. Hoffman, A. M. Mauer, and E. E. Vokes, “Lung cancer,” The Lancet, vol. 355, no. 9202, pp. 479–485, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Laviano, M. M. Meguid, A. Inui, M. Muscaritoli, and F. Rossi-Fanelli, “Therapy insight: cancer anorexia-cachexia syndrome—when all you can eat is yourself,” Nature Clinical Practice Oncology, vol. 2, no. 3, pp. 158–165, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. W. J. Evans, J. E. Morley, J. Argilés et al., “Cachexia: a new definition,” Clinical Nutrition, vol. 27, no. 6, pp. 793–799, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Gullett, P. Rossi, O. Kucuk, and P. A. S. Johnstone, “Cancer-induced cachexia: a guide for the oncologist,” Journal of the Society for Integrative Oncology, vol. 7, no. 4, pp. 155–169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Weyermann, R. Dallmann, J. Magyar et al., “Orally available selective melanocortin-4 receptor antagonists stimulate food intake and reduce cancer-induced cachexia in mice,” PLoS ONE, vol. 4, no. 3, Article ID e4774, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Finke, S. Ferrone, A. Frey, A. Mufson, and A. Ochoa, “Where have all the T cells gone? Mechanisms of immune evasion by tumors,” Immunology Today, vol. 20, no. 4, pp. 158–160, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Pawelec, S. Heinzel, R. Kiessling, L. Muller, Q. Ouyang, and J. Zeuthen, “Escape mechanisms in tumor immunity: a year 2000 update,” Critical Reviews in Oncogenesis, vol. 11, no. 2, pp. 97–133, 2000. View at Google Scholar · View at Scopus
  14. E. S. Ha, S. H. Hwang, K.-S. Shin et al., “Anti-metastatic activity of glycoprotein fractionated from Acanthopanax senticosus, involvement of NK-cell and macrophage activation,” Archives of Pharmacal Research, vol. 27, no. 2, pp. 217–224, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. K. M. Yoo and I. K. Hwang, “In vitro effect of Yuza (Citrus junos SIEB ex TANAKA) extracts on proliferation of human prostate cancer cells and antioxidant activity,” Korean Journal of Food Science and Technology, vol. 36, no. 2, pp. 339–344, 2004. View at Google Scholar
  16. Y.-A. Ham, H.-J. Choi, S.-H. Kim, M.-J. Chung, and S.-S. Ham, “Antimutagenic and antitumor effects of Adenophora triphylla extracts,” Journal of the Korean Society of Food Science and Nutrition, vol. 38, no. 1, pp. 25–31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. L.-K. Han, B.-J. Xu, Y. Kimura, Y.-N. Zheng, and H. Okuda, “Platycodi radix affects lipid metabolism in mice with high fat diet-induced obesity,” The Journal of Nutrition, vol. 130, no. 11, pp. 2760–2764, 2000. View at Google Scholar · View at Scopus
  18. L.-K. Han, Y.-N. Zheng, B.-J. Xu, H. Okuda, and Y. Kimura, “Saponins from Platycodi radix ameliorate high fat diet-induced obesity in mice,” Journal of Nutrition, vol. 132, no. 8, pp. 2241–2245, 2002. View at Google Scholar · View at Scopus
  19. H. L. Zhao, J.-S. Sim, S. H. Shim, Y. W. Ha, S. S. Kang, and Y. S. Kim, “Antiobese and hypolipidemic effects of platycodin saponins in diet-induced obese rats: evidences for lipase inhibition and calorie intake restriction,” International Journal of Obesity, vol. 29, no. 8, pp. 983–990, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. J. Hong, K. H. Shin, S. S. Lim et al., “Lead compounds for anti-inflammatory drugs isolated from the plants of the traditional oriental medicine in Korea,” Inflammation and Allergy—Drug Targets, vol. 7, no. 3, pp. 195–202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S.-S. Choi, E.-J. Han, T.-H. Lee, K.-J. Han, H.-K. Lee, and H.-W. Suh, “Antinociceptive profiles of platycodin D in the mouse,” The American Journal of Chinese Medicine, vol. 32, no. 2, pp. 257–268, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Xie, H.-X. Sun, and D. Li, “Platycodin D improves the immunogenicity of newcastle disease virus-based recombinant avian influenza vaccine in mice,” Chemistry and Biodiversity, vol. 7, no. 3, pp. 677–689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Q. Dai, Z. Chen, Y.-Q. Ge et al., “Mechanism of platycodin D-induced humane long cancer cells A549 apoptosis,” Zhongguo Zhongyao Zazhi, vol. 37, no. 17, pp. 2626–2629, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. S. Kim, J. S. Kim, S.-U. Choi et al., “Isolation of a new saponin and cytotoxic effect of saponins from the root of Platycodon grandiflorum on human tumor cell lines,” Planta Medica, vol. 71, no. 6, pp. 566–568, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Hennig, J. Ventura, R. Segersvard et al., “LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice,” Neoplasia, vol. 7, no. 4, pp. 417–425, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Wang, E. R. Rayburn, W. Wang, E. R. Kandimalla, S. Agrawal, and R. Zhang, “Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapy,” Molecular Cancer Therapeutics, vol. 5, no. 8, pp. 2106–2114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. K.-S. Kim, E.-K. Seo, Y.-C. Lee et al., “Effect of dietary Platycodon grandiflorum on the improvement of insulin resistance in obese Zucker rats,” The Journal of Nutritional Biochemistry, vol. 11, no. 9, pp. 420–424, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. P. Kim, E. B. Lee, S. Y. Kim et al., “Inhibition of prostaglandin E2 production by platycodin D isolated from the root of Platycodon grandiflorum,” Planta Medica, vol. 67, no. 4, pp. 362–364, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Nishimura, S. Yanoma, H. Mizuno, K. Kawakami, and M. Tsukuda, “An antioxidant, probucol, induces anti-angiogenesis and apoptosis in athymic nude mouse xenografted human head and neck squamous carcinoma cells,” Japanese Journal of Cancer Research, vol. 90, no. 11, pp. 1224–1230, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Iizuka, K. Miyamoto, S. Hazama et al., “Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6,” Cancer Letters, vol. 158, no. 1, pp. 35–41, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. H. R. Hubbell, K. Kvalnes-Krick, W. A. Carter, and D. R. Strayer, “Antiproliferative and immunomodulatory actions of β-interferon and double-stranded RNA, individually and in combination, on human bladder tumor xenografts in nude mice,” Cancer Research, vol. 45, no. 6, pp. 2481–2486, 1985. View at Google Scholar · View at Scopus
  32. H. S. Yoon, J. W. Kim, H. R. Cho et al., “Immunomodulatory effects of Aureobasidium pullulans SM-2001 exopolymers on the cyclophosphamide-treated mice,” Journal of microbiology and biotechnology, vol. 20, no. 2, pp. 438–445, 2010. View at Google Scholar · View at Scopus
  33. B. D. Clark, I. Bedrosian, R. Schindler et al., “Detection of interleukin 1α and 1β in rabbit tissues during endotoxemia using sensitive radioimmunoassays,” Journal of Applied Physiology, vol. 71, no. 6, pp. 2412–2418, 1991. View at Google Scholar · View at Scopus
  34. Y.-M. Jung, S.-H. Lee, D.-S. Lee et al., “Fermented garlic protects diabetic, obese mice when fed a high-fat diet by antioxidant effects,” Nutrition Research, vol. 31, no. 5, pp. 387–396, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. S.-R. Shi, B. Chaiwun, L. Young, R. J. Cote, and C. R. Taylor, “Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections,” Journal of Histochemistry and Cytochemistry, vol. 41, no. 11, pp. 1599–1604, 1993. View at Publisher · View at Google Scholar · View at Scopus
  36. T.-H. Kim, E.-G. Hur, S.-J. Kang et al., “NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α,” Cancer Research, vol. 71, no. 6, pp. 2260–2275, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. D.-H. Shin, H.-M. Park, K.-A. Jung et al., “The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis,” Free Radical Biology and Medicine, vol. 48, no. 8, pp. 1051–1063, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. J. H. Schiller, D. Harrington, C. P. Belani et al., “Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer,” The New England Journal of Medicine, vol. 346, no. 2, pp. 92–98, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Natale, “A ten-year review of progress in the treatment of non-small-cell lung cancer with gemcitabine,” Lung Cancer, vol. 50, supplement 1, pp. S2–S4, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. A. L. Visbal, N. B. Leighl, R. Feld, and F. A. Shepherd, “Adjuvant chemotherapy for early-stage non-small cell lung cancer,” Chest, vol. 128, no. 4, pp. 2933–2943, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. G. A. Silvestri and M. P. Rivera, “Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists,” Chest, vol. 128, no. 6, pp. 3975–3984, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. S.-Y. Han, M.-B. Zhao, G.-B. Zhuang, and P.-P. Li, “Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells,” Lung Cancer, vol. 75, no. 1, pp. 30–37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. S. S. Shord and S. R. Patel, “Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines,” Journal of Experimental and Clinical Cancer Research, vol. 28, no. 1, article 76, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. J. C. M. Clark, C. R. Dass, and P. F. M. Choong, “Development of chondrosarcoma animal models for assessment of adjuvant therapy,” ANZ Journal of Surgery, vol. 79, no. 5, pp. 327–336, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Kim, “Animal models of cancer in the head and neck region,” Clinical and Experimental Otorhinolaryngology, vol. 2, no. 2, pp. 55–60, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Holmstrom, R. T. Y. Wu, H. Zeng, K. Y. Lei, and W.-H. Cheng, “Nutritional and supranutritional levels of selenate differentially suppress prostate tumor growth in adult but not young nude mice,” The Journal of Nutritional Biochemistry, vol. 23, no. 9, pp. 1086–1091, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. J. D. Kennedy, C. W. Pierce, and J. P. Lake, “Extrathymic T cell maturation. Phenotypic analysis of T cell subsets in nude mice as a function of age,” Journal of Immunology, vol. 148, no. 6, pp. 1620–1629, 1992. View at Google Scholar · View at Scopus
  48. J.-Y. Lee, Y.-M. Lee, G.-C. Chang et al., “Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy,” PLoS ONE, vol. 6, no. 8, Article ID e23756, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Liu, Z. Jiang, G.-J. Teng et al., “Clinical and experimental study on regional administration of phosphorus-32 glass microspheres in treating hepatic carcinoma,” World Journal of Gastroenterology, vol. 5, no. 6, pp. 492–505, 1999. View at Google Scholar · View at Scopus
  50. J. M. Matés, J. A. Segura, F. J. Alonso, and J. Márquez, “Anticancer antioxidant regulatory functions of phytochemicals,” Current Medicinal Chemistry, vol. 18, no. 15, pp. 2315–2338, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Tsubura, Y.-C. Lai, M. Kuwata, N. Uehara, and K. Yoshizawa, “Anticancer effects of garlic and garlic-derived compounds for breast cancer control,” Anti-Cancer Agents in Medicinal Chemistry, vol. 11, no. 3, pp. 249–253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Sakai, S. Kokura, T. Ishikawa et al., “Effects of anticancer agents on cell viability, proliferative activity and cytokine production of peripheral blood mononuclear cells,” Journal of Clinical Biochemistry and Nutrition, vol. 52, no. 1, pp. 64–71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Suzuki, J. Sun, V. Kapoor, A. S. Jassar, and S. M. Albelda, “Gemcitabine has significant immunomodulatory activity in murine tumor models independent of its cytotoxic effects,” Cancer Biology and Therapy, vol. 6, no. 6, pp. 880–885, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Samira, C. Ferrand, A. Peled et al., “Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice,” Stem Cells, vol. 22, no. 6, pp. 1085–1100, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Isaacs, “Lymphokines and cytokines,” in Immunology: An Introduction, I. R. Tizard, Ed., pp. 155–169, Saunders, Philadelphia, Pa, USA, 1995. View at Google Scholar
  56. E. R. Unanue, “The mononuclear-phagocytic sytem,” in Immunology: An Introduction, I. R. Tizard, Ed., pp. 61–74, Saunders, Philadelphia, Pa, USA, 1995. View at Google Scholar
  57. G. Nuñez, M. A. Benedict, Y. Hu, and N. Inohara, “Caspases: the proteases of the apoptotic pathway,” Oncogene, vol. 17, no. 25, pp. 3237–3245, 1998. View at Google Scholar · View at Scopus
  58. K. L. Barrett, J. M. Willingham, A. J. Garvin, and M. C. Willingham, “Advances in cytochemical methods for detection of apoptosis,” The Journal of Histochemistry and Cytochemistry, vol. 49, no. 7, pp. 821–832, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Trucco, F. J. Oliver, G. de Murcia, and J. Ménissier-de Murcia, “DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines,” Nucleic Acids Research, vol. 26, no. 11, pp. 2644–2649, 1998. View at Publisher · View at Google Scholar · View at Scopus
  60. M. E. Smulson, D. Pang, M. Jung et al., “Irreversible binding of poly(ADP)ribose polymerase cleavage product to DNA ends revealed by atomic force microscopy: possible role in apoptosis,” Cancer Research, vol. 58, no. 16, pp. 3495–3498, 1998. View at Google Scholar · View at Scopus
  61. P. G. Smyth, S. A. Berman, and S. Bursztajn, “Markers of apoptosis: methods for elucidating the mechanism of apoptotic cell death from the nervous system,” BioTechniques, vol. 32, no. 3, pp. 648–665, 2002. View at Google Scholar · View at Scopus
  62. E. F. Fang, C. Z. Y. Zhang, L. Zhang et al., “Trichosanthin inhibits breast cancer cell proliferation in both cell lines and nude mice by promotion of apoptosis,” PLoS ONE, vol. 7, no. 9, Article ID e41592, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. Y. Qin, C. Y. Sun, F. R. Lu et al., “Cardamonin exerts potent activity against multiple myeloma through blockade of NF-κB pathway in vitro,” Leukemia Research, vol. 36, no. 4, pp. 514–520, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Chell, A. Kadi, A. Caroline Williams, and C. Paraskeva, “Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer,” Biochimica et Biophysica Acta, vol. 1766, no. 1, pp. 104–119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. G. J. Southan and C. Szabó, “Selective pharmacological inhibition of distinct nitric oxide synthase isoforms,” Biochemical Pharmacology, vol. 51, no. 4, pp. 383–394, 1996. View at Publisher · View at Google Scholar · View at Scopus
  66. V. Kostourou, J. E. Cartwright, A. P. Johnstone et al., “The role of tumour-derived iNOS in tumour progression and angiogenesis,” British Journal of Cancer, vol. 104, no. 1, pp. 83–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. K. Xie, S. Huang, Z. Dong et al., “Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells,” The Journal of Experimental Medicine, vol. 181, no. 4, pp. 1333–1343, 1995. View at Publisher · View at Google Scholar · View at Scopus
  68. J. Yan, Q. Wang, X. Zheng et al., “Luteolin enhances TNF-related apoptosis-inducing ligand's anticancer activity in a lung cancer xenograft mouse model,” Biochemical and Biophysical Research Communications, vol. 417, no. 2, pp. 842–846, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Inui, “Cancer anorexia-cachexia syndrome: are neuropeptides the key?” Cancer Research, vol. 59, no. 18, pp. 4493–4501, 1999. View at Google Scholar · View at Scopus
  70. M. J. Tisdale, “Biology of cachexia,” Journal of the National Cancer Institute, vol. 89, no. 23, pp. 1763–1773, 1997. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Fujita, T. Tsujinaka, M. Yano et al., “Anti-interleukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma-bearing mice with modulation of lysosomal and ATP-ubiquitin-dependent proteolytic pathways,” International Journal of Cancer, vol. 68, no. 5, pp. 637–643, 1996. View at Google Scholar
  72. J. Kurebayashi, S. Yamamoto, T. Otsuki, and H. Sonoo, “Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect,” British Journal of Cancer, vol. 79, no. 3-4, pp. 631–636, 1999. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Strassmann, M. Fong, J. S. Kenney, and C. O. Jacob, “Evidence for the involvement of interleukin 6 in experimental cancer cachexia,” Journal of Clinical Investigation, vol. 89, no. 5, pp. 1681–1684, 1992. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Oka, K. Yamamoto, M. Takahashi et al., “Relationship between serum levels of interleukin 6, various disease parameters, and malnutrition in patients with esophageal squamous cell carcinoma,” Cancer Research, vol. 56, no. 12, pp. 2776–2780, 1996. View at Google Scholar · View at Scopus